Can Deep Brain Stimulation Unlock Treatment

Key Points:

• Approximately 30% of people with depression suffer from treatment-resistant depression, where standard medications and therapy fail to provide relief; researchers are exploring Deep Brain Stimulation (DBS) as a potential treatment option for these patients.
• DBS, approved for movement disorders like Parkinson’s, uses implanted electrodes to deliver electrical pulses targeting the brain’s white matter, aiming to "unstick" the brain from chronic depressive states, with effects typically unfolding over weeks or months.
• UT Southwestern is participating in the TRANSCEND trial, a double-blind, placebo-controlled study investigating DBS for depression, enrolling adults with severe, long-term depression unresponsive to multiple treatments.
• DBS for depression differs from its use in movement disorders by targeting white matter rather than gray matter, and is not an immediate "happy switch" but seeks to reduce biological barriers to improve mood and engagement in life activities gradually.
• While DBS is currently only available through clinical trials, positive results from ongoing studies like TRANSCEND could lead to FDA approval and wider availability within the next five years, offering hope for patients with difficult-to-treat depression.